tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
TCRR is currently covered by 7 analysts with an average price target of $10.96. This is a potential upside of $10.96 (0%) from yesterday's end of day stock price of $0.
Tcr2 Therapeutics's activity chart (see below) currently has 31 price targets and 34 ratings on display. The stock rating distribution of TCRR is 36.36% BUY and 63.64% HOLD.
Analysts average stock forecasts to be materialized ratio is 28.13% with an average time for these price targets to be met of 98.38 days.
Highest price target for TCRR is $2.11, Lowest price target is $2.11, average price target is $10.96.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 12-May-2023. First documented stock forecast 11-Mar-2019.
Currently out of the existing stock ratings of TCRR, 4 are a BUY (36.36%), 7 are a HOLD (63.64%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2.11
$0.63 (42.57%)
1.72
11 months 12 days ago
1/2 (50%)
$0.15 (7.65%)
26
Hold
1 years 1 months 17 days ago
0/2 (0%)
$15.09 (385.93%)
Hold
3
$1.52 (102.70%)
1 years 1 months 17 days ago
0/2 (0%)
$1.4 (87.50%)
Buy
26
1 years 3 months 18 days ago
0/5 (0%)
$19.92 (327.63%)
Hold
2
$0.52 (35.14%)
3
1 years 5 months 16 days ago
2/4 (50%)
$0.64 (47.06%)
1
What is TCRR (Tcr2 Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TCRR (Tcr2 Therapeutics) with a proven track record?
Which analyst has the current lower performing score on TCRR (Tcr2 Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TCRR (Tcr2 Therapeutics)?
Which analyst is the currently most bullish on TCRR (Tcr2 Therapeutics)?
Which analyst is the currently most reserved on TCRR (Tcr2 Therapeutics)?
